37 results match your criteria: "Montpellier University Hospital and Montpellier University[Affiliation]"
Contact Dermatitis
December 2024
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Background: 2-(Thiocyanomethylthio)benzothiazole (TCMTB) is a fungicide product widely used in the leather industry, particularly since the 1990s. However, reports of allergic contact dermatitis triggered by this chemical are scarce.
Objectives: To investigate three cases of dermatitis following contact with leather products, possibly related to TCMTB.
J Eur Acad Dermatol Venereol
December 2024
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Contact Dermatitis
November 2024
Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.
J Eur Acad Dermatol Venereol
August 2024
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Contact Dermatitis
November 2024
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Contact Dermatitis
October 2024
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Contact Dermatitis
August 2024
National Allergy Research Centre, Department of Skin and Allergy, University of Copenhagen, Gentofte Hospital, Copenhagen, Denmark.
Patch testing is the only clinically applicable diagnostic method for Type IV allergy. The availability of Type IV patch test (PT) allergens in Europe, however, is currently scarce. This severely compromises adequate diagnostics of contact allergy, leading to serious consequences for the affected patients.
View Article and Find Full Text PDFContact Dermatitis
September 2024
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
J Eur Acad Dermatol Venereol
January 2025
Department of Dermatology, Nîmes University Hospital and Montpellier University, Nîmes, France.
Contact Dermatitis
July 2024
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Contact Dermatitis
July 2024
Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.
Contact Dermatitis
March 2024
Department of Dermatology, Allergology Unit, Montpellier University Hospital and Montpellier University, Montpellier, France.
Osteoporos Int
February 2024
Department of Neuromedicine and Movement Science, NTNU, Trondheim, Norway.
Few older adults regain their pre-fracture mobility after a hip fracture. Intervention studies evaluating effects on gait typically use short clinical tests or in-lab parameters that are often limited to gait speed only. Measurements of mobility in daily life settings exist and should be considered to a greater extent than today.
View Article and Find Full Text PDFContact Dermatitis
December 2023
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Contact Dermatitis
November 2023
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Dermatitis
March 2024
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
J Eur Acad Dermatol Venereol
October 2023
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Contact Dermatitis
August 2023
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Contact Dermatitis
August 2023
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
J Allergy Clin Immunol Pract
August 2023
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France; Department of Pulmonology, Allergology Division, Montpellier University Hospital and Montpellier University, Montpellier, France; IDESP, Institut Desbrest d'Epidémiologie et de Santé Publique, UMR INSERM - Montpellier University, Montpellier, France. Electronic address:
Contact Dermatitis
May 2023
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Clin Exp Dermatol
December 2022
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
We present the first case of a localized salt-dependent aquagenic urticaria confirmed by a challenge test. A good therapeutic response was achieved after only the first dose of omalizumab.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
July 2023
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Background: Anti-PD1 agents are currently recommended as first-line treatment in advanced cutaneous squamous cell carcinoma (acSCC) by updated European guidelines. Although acSCC frequently affects elderly patients with multiple comorbidities, this subset of patients is often excluded of registration clinical trials.
Purpose: To assess anti-PD-1 efficacy and safety in elderly acSCC patients in real-life conditions and describe this specific population with oncogeriatric evaluation tools.
Clin Exp Dermatol
July 2022
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Association of an acquired aquagenic keratoderma and an aquagenic urticaria.
View Article and Find Full Text PDFContact Dermatitis
April 2022
Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France.
Background: Allergic contact dermatitis (ACD) and photoallergic contact dermatitis (PACD) to benzophenone present in printing ink have been reported. However, precise chemical analyses and extended photo-patch tests have not been performed in these cases.
Objectives: To determine which components present in a magazine cover are responsible for a patient's skin reaction, to determine the primary sensitizer, and precisely diagnose ACD and PACD.